New York: Almost 500 million people have been infected with the coronavirus since March 2020 and new variants are still a threat. This Friday marks two years since the World Health Organization (WHO) characterised the global spread of COVID-19 as a pandemic. more
WHO: 2022 can mark the end of COVID's acute stage

New York: The UN health agency chief expressed optimism during a press briefing on Wednesday that 2022 maybe the year the world ends the acute stage of the COVID-19 pandemic. 

‘Consistent evidence’ of Omicron’s spread vs Delta: WHO’s Tedros

New York: There is now “consistent evidence” that the Omicron variant is outpacing Delta, as COVID-19 continues to account for around 50,000 deaths worldwide every week, said ...

Omicron, Delta may combine to form COVID-19 super-variant, expert warns

London: A new COVID-19 super-variant strain may emerge with the combination of Delta and Omicron variants, experts said.

New Zealand registers 95 new community cases of Delta variant

Wellington/UNI/Xinhua: New Zealand reported 95 new cases of the Delta variant in the community on Friday, bringing the total number of the confirmed cases of COVID-19 in the country's ...

COVID-19 Delta variant still ‘most concerning’, say WHO experts

New York: Even with the emergence of the new Mu COVID-19 variant, the Delta strain remains the top concern globally, appearing to “outcompete” others, senior officials with th ...

Delta variant doubles risk of COVID-19 hospitalisation compared to alpha variant: Study

New York: People infected with the SARS-CoV-2 delta variant have approximately double the risk of hospitalisation compared with those infected with the alpha variant, a study of more than ...

Coronavirus: New Zealand reports six new Delta cases

Wellington: New Zealand has reported six new  Delta  COVID-19 cases which include one fully vaccinated nurse from  an Auckland hospital, media reports said.

Australia: Lockdown imposed in Brisbane after Delta virus infection cases emerge

Brisbane: Lockdown is back in several Australian regions as  the highly contagious Delta variant continues to spread in the nation.

COVAXIN generates antibodies which effectively neutralize Alpha and Delta variants of coronavirus, says US health research institute

Washington: A study conducted by  the US' National Institute of Health has said India's COVAXIN, which was developed by Bharat Biotech in collaboration with the Indian Counci ...